<DOC>
	<DOC>NCT01695824</DOC>
	<brief_summary>The primary objective of this study is to assess combined end point (All stroke, Systemic embolism, Cardiovascular death) between two groups.</brief_summary>
	<brief_title>Left Atrial Appendage (LAA) Occluders After Catheter Ablation of Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patient has paroxysmal, persistent or permanent nonvalvular atrial fibrillation (AF) Eligible for long term warfarin CHADS score &gt;= 1 (congestive heart failure [CHF], history of high blood pressure, 75 years of age or older, diabetes, prior stroke or transient ischemic attack [TIA]) Contraindicated for warfarin Contraindicated for aspirin or clopidogrel (Plavix) CHF Class 4 Implanted mechanical valve Atrial septal or Patent Foramen Ovale (PFO) device Platelets &lt; 100,000 or hemoglobin &lt; 10 Left ventricular ejection fraction (LVEF) &lt; 30%</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>catheter ablation</keyword>
</DOC>